54 results match your criteria: "Federation hospitalo-universitaire INCREASE[Affiliation]"
The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.
Rheumatology (Oxford)
September 2015
Université de Franche Comté, UPRES EA 4266 Agents Pathogènes et Inflammation, Besançon, INSERM, CIC 1431, Centre investigation Clinique Biothérapie, Fédération Hospitalo-Universitaire INCREASE, CHRU, CHRU Besançon, Rhumatologie and Université de Franche Comté, Département Universitaire de Thérapeutique, Besançon, France
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipients.
Am J Transplant
April 2015
INSERM, UMR1098, Federation Hospitalo-Universitaire INCREASE, Besançon, France; Université de Franche-Comté, Faculté de Médecine et de Pharmacie, Besançon, France; Structure Fédérative de Recherche, SFR FED4234, Besançon, France; CHU Besançon, Department of Nephrology, Dialysis, and Renal Transplantation, Besançon, France.
Persistent ATG-induced CD4(+) T cell lymphopenia is associated with serious clinical complications. We tested the hypothesis that ATG induces accelerated immune senescence in renal transplant recipients (RTR). Immune senescence biomarkers were analyzed at transplant and one-year later in 97 incident RTR -62 patients receiving ATG and 35 receiving anti-CD25 mAb (α-CD25).
View Article and Find Full Text PDFSerum immunoglobulin G levels and peritonitis in peritoneal dialysis patients.
J Nephrol
August 2015
INSERM UMR1098, Fédération Hospitalo-Universitaire INCREASE, 25020, Besançon, France.
Background: Peritonitis is a frequent and serious complication of peritoneal dialysis (PD). Whether low immunoglobulin level is associated with PD-related peritonitis is unknown.
Methods: We conducted a prospective study to assess whether immunoglobulin levels at PD onset could predict the occurrence of peritonitis.
Regulatory T cells and cancer: an undesired tolerance.
Kidney Int
July 2014
1] Unité Mixte de Recherche INSERM 1098, Fédération Hospitalo-Universitaire INCREASE, Besançon, France [2] Université de Franche-Comté Institut Fédératif de Recherche 133, Besançon, France [3] Centre Hospitalier Universitaire, Besançon, France [4] Centre d'Investigation Clinique en Biothérapies 506, Besançon, France.
The incidence of cancer is markedly increased in organ transplant patients. A better understanding of underlying mechanisms and the identification of biomarkers for diagnosis and prognosis are major challenges. Hope et al.
View Article and Find Full Text PDF